Analysts forecast that XOMA Corporation (NASDAQ:XOMA) will report sales of $770,000.00 for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for XOMA Corporation’s earnings. The highest sales estimate is $1.17 million and the lowest is $370,000.00. XOMA Corporation reported sales of $640,000.00 in the same quarter last year, which would suggest a positive year-over-year growth rate of 20.3%. The business is scheduled to report its next earnings report on Wednesday, November 8th.

On average, analysts expect that XOMA Corporation will report full-year sales of $770,000.00 for the current year, with estimates ranging from $11.90 million to $13.22 million. For the next financial year, analysts anticipate that the firm will report sales of $7.79 million per share, with estimates ranging from $4.63 million to $10.95 million. Zacks’ sales averages are an average based on a survey of sell-side research firms that that provide coverage for XOMA Corporation.

Several equities research analysts have weighed in on XOMA shares. Wedbush upgraded shares of XOMA Corporation from a “neutral” rating to an “outperform” rating and raised their price objective for the company from $9.00 to $19.00 in a research report on Tuesday, September 5th. Zacks Investment Research upgraded shares of XOMA Corporation from a “sell” rating to a “hold” rating in a research report on Tuesday, September 19th. HC Wainwright restated a “buy” rating and issued a $15.00 price objective on shares of XOMA Corporation in a research report on Thursday, August 10th. Finally, ValuEngine upgraded shares of XOMA Corporation from a “strong sell” rating to a “sell” rating in a research report on Wednesday, July 12th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $14.00.

Shares of XOMA Corporation (NASDAQ XOMA) traded up 1.1506% during mid-day trading on Wednesday, hitting $22.6375. 25,539 shares of the stock were exchanged. The company’s 50-day moving average is $17.04 and its 200-day moving average is $9.46. XOMA Corporation has a 1-year low of $3.96 and a 1-year high of $23.58. The firm’s market cap is $172.00 million.

A hedge fund recently raised its stake in XOMA Corporation stock. California Public Employees Retirement System lifted its holdings in shares of XOMA Corporation (NASDAQ:XOMA) by 95.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,780 shares of the biotechnology company’s stock after buying an additional 10,640 shares during the quarter. California Public Employees Retirement System owned about 0.29% of XOMA Corporation worth $123,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 32.92% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This article was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international trademark and copyright law. The legal version of this article can be read at https://www.americanbankingnews.com/2017/10/11/brokerages-anticipate-xoma-corporation-xoma-will-announce-quarterly-sales-of-770000-00.html.

About XOMA Corporation

XOMA Corporation is a development-stage biotechnology company. The Company focuses on the discovery and development of monoclonal antibody-based therapeutics. It has five products in its endocrine portfolio, two of which are developed as part of its XOMA Metabolism (XMet) platform. Its products include XOMA 358, XOMA 129, XOMA 213 and Gevokizumab.

Get a free copy of the Zacks research report on XOMA Corporation (XOMA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for XOMA Corporation (NASDAQ:XOMA)

Receive News & Ratings for XOMA Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA Corporation and related companies with MarketBeat.com's FREE daily email newsletter.